Table 1.
Fibroblast markers3,18 | CAF positive markers | CAF negative markers | CAF subtype markers8 | ||
---|---|---|---|---|---|
myCAF | iCAF | apCAF | |||
ACTA2 | PDGFRα / PDGFRβ19 | CD458 | ACTA2 | IL6/IL8 | H2-Ab1 |
VIM | DDR220 | CD318 | TAGLN | PDGFRA | CD74 |
COL1 | COL18 | EPCAM8 | MMP11 | CXCL1/CXCL2/CXCL12; CCL2 | SLPI |
FSP1 (also known as S100A4) | FAP8 | PECAM118 | HOPX | CFD | SAA3 |
FAP | PDPN8 | NG219 | POSTN | DPT | |
DES | DCN8 | TPM1/TPM2 | LMNA | ||
VIM8 | AGTR1 | ||||
HAS1 |
ACTA2 actin alpha 2, VIM vimentin, COL1 collagen type I, FSP1 fibroblast-specific protein 1, FAP fibroblast activation protein, DES desmin, DDR2 discoidin domain-containing receptor 2, PDPN podoplanin, DCN decorin, PECAM1 platelet/endothelial cell adhesion molecule, EPCAM epithelial cell adhesion molecule, TAGLN transgelin, MMP11 matrix metallopeptidase 11, HOPX homeobox transcription factor, TPM1/TPM2 tropomyosin 1/2, CFD complement factor D, DPT dermatopontin, LMNA lamin A, AGTR1 angiotensin II receptor type 1, CXCL CXC-chemokine ligand, Has1 hyaluronan synthase, H2-Ab1 histocompatibility 2, class II antigen A beta 1 gene, SLPI Peptidase inhibitor, Saa3 serum amyloid A3.